We found 11 online brokers that are appropriate for Trading Glaxosmithkline Marketshare Investment Platforms.

There is no doubting the fact that Glaxosmithkline is one of the biggest names in the pharmaceutical industry. Its achievements are not just within the US but tend to span to other countries around the world. This global vaccine producer has been able to meet the expectations and needs of investors over the years with some great performances. For instance, its revenues were reported to be around £30.82 billion. From such a figure, revenues generated from other countries were about 10 billion dollars.
As mentioned above, Glaxosmithkline has proven to be one of the powerhouses when pharmaceutical companies are being mentioned. Proof of this is that its market share is about 4.19%. Based on revenue, it maintains position number 6 amongst other notable companies like Sanofi, AbbVie Inc, Bayer AG and many others.
Glaxosmithkline is a company in the healthcare market which is highly specialized in researching, developing, manufacturing of vaccines, medicines and other consumer products. Its vaccine segment has been the most active and successful over the years. This is where vaccines are manufactured to ensure the prevention of infectious diseases like bacterial meningitis, influenza, typhoid, polio, rubella, measles and cough.
The advent of Covid-19 has made lots of companies experience huge losses. Business activities have been brought to a halt due to restrictions. Investors on the other hand, experienced a huge loss as most of their shares decreased in value leading to a huge sell-off. Many people do not see Glaxosmithkline as something that is worth investing in. Entertaining such thought can only be traced to the fact that you lack knowledge about this company, including its recent projects.
For instance, it is currently partnering with CureVac to produce a vaccine. According to most experts, this will be one of the most potent vaccines that has ever been created against Covid-19. Right now, this innovation has been discovered to have almost 80% potency. Of course, there have been numerous vaccines on the market. However, none has been able to hit the standard that this one has attained.
In the month of June when this vaccine went through the trials, it was not encouraging. However, things are looking up for both companies as recent trials and results show its immune system has been boosted.
It is true that Glaxosmithkline currently has a large market share that makes it rank amongst some of the best pharmaceutical companies in the world. However, it is looking to gain more market share with the emergence of such a vaccine. Have you ever imagined what could happen once it gets released into the market? Most of the vaccines that have been manufactured are good but they have had one limitation or another.
The vaccine created by Glaxosmithkline is an upgrade of those that are presently in the market. This means it is more effective and potent to fight against Covid-19. Based on this, experts are expecting that Glaxosmithkline will gain more market share and even generate higher revenues in the coming years. Although only time will tell about this development, there is no doubting the fact that the company has plans of being more competitive.
Right now, its stock is $38.39 and experts are claiming it is a huge bargain. This is because the company is viewed as one with very huge potentials. With a market cap of over 90 billion dollars, you may want to consider taking advantage of what this company has to offer. It is also important to point out that the pharmaceutical industry is evergreen. This is why it has been valued to worth billions of dollars. So as long as companies are producing potent drugs and vaccines, they will always have huge markets that such can be sold to.
The conclusion is that Glaxosmithkline has a huge market share. This makes it a great place to put your funds for high returns in the future. The best part is that it has the chance of increasing such market share beyond its present state. This company definitely looks promising.
We have conducted extensive research and analysis on over multiple data points on Glaxosmithkline Marketshare to present you with a comprehensive guide that can help you find the most suitable Glaxosmithkline Marketshare. Below we shortlist what we think are the best Glaxosmithkline Marketshare Investment Platforms after careful consideration and evaluation. We hope this list will assist you in making an informed decision when researching Glaxosmithkline Marketshare.
Selecting a reliable and reputable online Glaxosmithkline Marketshare Investment Platforms trading brokerage involves assessing their track record, regulatory status, customer support, processing times, international presence, and language capabilities. Considering these factors, you can make an informed decision and trade Glaxosmithkline Marketshare Investment Platforms more confidently.
Selecting the right online Glaxosmithkline Marketshare Investment Platforms trading brokerage requires careful consideration of several critical factors. Here are some essential points to keep in mind:
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
When choosing a broker for Glaxosmithkline Marketshare Investment Platforms trading, it's essential to compare the different options available to you. Our Glaxosmithkline Marketshare Investment Platforms brokerage comparison table below allows you to compare several important features side by side, making it easier to make an informed choice.
By comparing these essential features, you can choose a Glaxosmithkline Marketshare Investment Platforms broker that best suits your needs and preferences for Glaxosmithkline Marketshare Investment Platforms. Our Glaxosmithkline Marketshare Investment Platforms broker comparison table simplifies the process, allowing you to make a more informed decision.
Here are the top Glaxosmithkline Marketshare Investment Platforms.
Compare Glaxosmithkline Marketshare Investment Platforms brokers for min deposits, funding, used by, benefits, account types, platforms, and support levels. When searching for a Glaxosmithkline Marketshare Investment Platforms broker, it's crucial to compare several factors to choose the right one for your Glaxosmithkline Marketshare Investment Platforms needs. Our comparison tool allows you to compare the essential features side by side.
All brokers below are Glaxosmithkline Marketshare Investment Platforms. Learn more about what they offer below.
You can scroll left and right on the comparison table below to see more Glaxosmithkline Marketshare Investment Platforms that accept Glaxosmithkline Marketshare Investment Platforms clients.
| Broker |
IC Markets
|
Roboforex
|
eToro
|
XTB
|
XM
|
Pepperstone
|
AvaTrade
|
FP Markets
|
EasyMarkets
|
SpreadEx
|
FXPro
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rating | |||||||||||
| Regulation | Seychelles Financial Services Authority (FSA) (SD018) | RoboForex Lid is regulated by Belize FSC, License No. 000138/7, reg. number 000001272. RoboForex Ltd, which is an (A category) member of The Financial Commission, also is a participant of its Compensation Fund | FCA (Financial Conduct Authority) eToro (UK) Ltd (FCA reference 583263), eToro (Europe) Ltd CySEC (Cyprus Securities Exchange Commission), ASIC (Australian Securities and Investments Commission) eToro AUS Capital Limited ASIC license 491139, CySec (Cyprus Securities and Exchange Commission under the license 109/10), FSAS (Financial Services Authority Seychelles) eToro (Seychelles) Ltd license SD076 | FCA (Financial Conduct Authority reference 522157), CySEC (Cyprus Securities and Exchange Commission reference 169/12), FSCA (Financial Sector Conduct Authority), XTB AFRICA (PTY) LTD licensed to operate in South Africa, KPWiG (Polish Securities and Exchange Commission), DFSA (Dubai Financial Services Authority), DIFC (Dubai International Financial Center), CNMV (Comisión Nacional del Mercado de Valores), KNF (Komisja Nadzoru Finansowego), IFSC (Belize International Financial Services Commission license number IFSC/60/413/TS/19) | Financial Services Commission (FSC) (000261/27) XM ZA (Pty) Ltd, Cyprus Securities and Exchange Commission (CySEC) (license 120/10) Trading Point of Financial Instruments Ltd, Australian Securities and Investments Commission (ASIC) (number 443670) Trading Point of Financial Instruments Pty Ltd | Financial Conduct Authority (FCA), Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), Federal Financial Supervisory Authority (BaFin), Dubai Financial Services Authority (DFSA), Capital Markets Authority of Kenya (CMA), Pepperstone Markets Limited is incorporated in The Bahamas (number 177174 B), Licensed by the Securities Commission of the Bahamas (SCB) number SIA-F217 | Australian Securities and Investments Commission (ASIC) Ava Capital Markets Australia Pty Ltd (406684), South African Financial Sector Conduct Authority (FSCA) Ava Capital Markets Pty Ltd (45984), Financial Services Agency (Japan FSA) Ava Trade Japan K.K. (1662), Financial Futures Association of Japan (FFAJ),, FFAJ, Abu Dhabi Global Markets (ADGM)(190018) Ava Trade Middle East Ltd (190018), Polish Financial Supervision Authority (KNF) AVA Trade EU Ltd, Central Bank of Ireland (C53877) AVA Trade EU Ltd, British Virgin Islands Financial Services Commission (BVI) BVI (SIBA/L/13/1049), Israel Securities Association (ISA) (514666577) ATrade Ltd, Financial Regulatory Services Authority (FRSA) | CySEC (Cyprus Securities and Exchange Commission) (371/18), ASIC AFS (Australian Securities and Investments Commission) (286354), FSP (Financial Sector Conduct Authority in South Africa) (50926), Financial Services Authority Seychelles (FSA) (130) | Easy Forex Trading Ltd is regulated by CySEC ( License Number 079/07). Easy Forex Trading Ltd is the only entity that onboards EU clients, easyMarkets Pty Ltd is regulated by ASIC ( AFS License No. 246566), EF Worldwide Ltd in Seychelles is regulated by FSA ( License Number SD056), EF Worldwide Ltd in British Virgin Islands is regulated by FSC (License Number SIBA/L/20/1135), | FCA (Financial Conduct Authority) (190941), Gambling Commission (Great Britain) (8835) | FCA (Financial Conduct Authority) (509956), CySEC (Cyprus Securities and Exchange Commission) (078/07), FSCA (Financial Sector Conduct Authority) (45052), SCB (Securities Commission of The Bahamas) (SIA-F184), FSA (Financial Services Authority of Seychelles) (SD120) |
| Min Deposit | 200 | 10 | 50 | No minimum deposit | 5 | No minimum deposit | 100 | 100 | 25 | No minimum deposit | 100 |
| Funding |
|
|
|
|
|
|
|
|
|
|
|
| Used By | 200,000+ | 730,000+ | 40,000,000+ | 1,000,000+ | 10,000,000+ | 400,000+ | 400,000+ | 200,000+ | 250,000+ | 60,000+ | 7,800,000+ |
| Benefits |
|
|
|
|
|
|
|
|
|
|
|
| Accounts |
|
|
|
|
|
|
|
|
|
|
|
| Platforms | MT5, MT4, MetaTrader WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), MetaTrader iPhone/iPad, MetaTrader Android Google Play, MetaTrader Mac, cTrader, cTrader Web, cTrader iPhone/iPad, cTrader iMac, cTrader Android Google Play, cTrader Automate, cTrader Copy Trading, TradingView, Virtual Private Server, Trading Servers, MT4 Advanced Trading Tools, IC Insights, Trading Central | MT4, MT5, R Mobile Trader, R StocksTrader, WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), Windows | eToro Trading App, Mobile Apps, iOS (App Store), Android (Google Play), CopyTrading, Web | MT4, Mirror Trader, Web Trader, Tablet, Mobile Apps, iOS (App Store), Android (Google Play) | MT5, MT5 WebTrader, XM Apple App for iPhone, XM App for Android Google Play, Tablet: MT5 for iPad, MT5 for Android Google Play, XM App for iPad, XM App for iOS (App Store), Android (Google Play), Mobile Apps | MT4, MT5, cTrader,WebTrader, TradingView, Windows, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, Web Trading, AvaTrade App, AvaOptions, Mac Trading, AvaSocial, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, TradingView, cTrader, WebTrader, Mobile Trader, Mobile Apps, iOS (App Store), Android (Google Play) | easyMarkets App, Mobile Apps, iOS (App Store), Android (Google Play), Web Platform, TradingView, MT4, MT5 | Web, Mobile Apps, iOS (App Store), Android (Google Play), iPad App, iPhone App, TradingView | MT4, MT5, cTrader, FxPro WebTrader, FxPro Mobile Apps, iOS (App Store), Android (Google Play) |
| Support |
|
|
|
|
|
|
|
|
|
|
|
| Learn More |
Sign
Up with icmarkets |
Sign
Up with roboforex |
Sign
Up with etoro |
Sign
Up with xtb |
Sign
Up with xm |
Sign
Up with pepperstone |
Sign
Up with avatrade |
Sign
Up with fpmarkets |
Sign
Up with easymarkets |
Sign
Up with spreadex |
Sign
Up with fxpro |
| Risk Warning | Losses can exceed deposits | Losses can exceed deposits | 61% of retail investor accounts lose money when trading CFDs with this provider. | 69% - 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.99% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | 75-95 % of retail investor accounts lose money when trading CFDs | 71% of retail investor accounts lose money when trading CFDs with this provider | Losses can exceed deposits | Your capital is at risk | 65% of retail CFD accounts lose money | 75.78% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider |
| Demo |
IC Markets Demo |
Roboforex Demo |
eToro Demo |
XTB Demo |
XM Demo |
Pepperstone Demo |
AvaTrade Demo |
FP Markets Demo |
easyMarkets Demo |
SpreadEx Demo |
FxPro Demo |
| Excluded Countries | US, IR, CA, NZ, JP | AU, BE, BQ, BR, CA, CW, CZ, DE, ES, EE, EU, FM, FR, FI, GW, ID, IR, JP, LR, MP, NL, PF, PL, RU, SE, SJ, SS, SL, SI, TL, TR, DO, US, IT, AT, PT, BG, HR, CY, DK, FL, GR, IE, LV, LT, MT, RO, SK, CH | ZA, ID, IR, KP, BE, CA, JP, SY, TR, IL, BY, AL, MD, MK, RS, GN, CD, SD, SA, ZW, ET, GH, TZ, LY, UG, ZM, BW, RW, TN, SO, NA, TG, SL, LR, GM, DJ, CI, PK, BN, TW, WS, NP, SG, VI, TM, TJ, UZ, LK, TT, HT, MM, BT, MH, MV, MG, MK, KZ, GD, FJ, PT, BB, BM, BS, AG, AI, AW, AX, LB, SV, PY, HN, GT, PR, NI, VG, AN, CN, BZ, DZ, MY, KH, PH, VN, EG, MN, MO, UA, JO, KR, AO, BR, HR, GL, IS, IM, JM, FM, MC, NG, SI, | US, IN, PK, BD, NG , ID, BE, AU | US, CA, IL, IR | AF, AS, AQ, AM, AZ, BY, BE, BZ, BT, BA, BI, CM, CA, CF, TD, CG, CI, ER, GF, PF, GP, GU, GN, GW, GY, HT, VA, IR, IQ, JP, KZ, LB, LR, LY, ML, MQ, YT, MZ, MM, NZ, NI, KP, PS, PR, RE, KN, LC, VC, WS, SO, GS, KR, SS, SD, SR, SY, TJ, TN, TM, TC, US, VU, VG, EH, ES, YE, ZW, ET | BE, BR, KP, NZ, TR, US, CA, SG | US, JP, NZ | US, IL, BC, MB, QC, ON, AF, BY, BI, KH, KY, TD, KM, CG, CU, CD, GQ, ER, FJ, GN, GW, HT, IR, IQ, LA, LY, MZ, MM, NI, KP, PW, PA, RU, SO, SS, SD, SY, TT, TM, VU, VE, YE | US, TR | US, CA, IR |
You can compare Glaxosmithkline Marketshare Investment Platforms ratings, min deposits what the the broker offers, funding methods, platforms, spread types, customer support options, regulation and account types side by side.
We also have an indepth Top Glaxosmithkline Marketshare Investment Platforms for 2025 article further below. You can see it now by clicking here
We have listed top Glaxosmithkline Marketshare Investment Platforms below.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 61% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
This communication is intended for information and educational purposes only and should not be considered investment advice or investment recommendation. Past performance is not an indication of future results.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Crypto investments are risky and highly volatile. Tax may apply. Understand the risks here.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.
Losses can exceed deposits